| Line 4: |
Line 4: |
| | ! Receptor !! Binding Affinity !! Effects !! Mechanism !! Agonists !! Antagonists | | ! Receptor !! Binding Affinity !! Effects !! Mechanism !! Agonists !! Antagonists |
| | |- | | |- |
| − | | Alpha-1 || Norepi > Epi >> Iso || Smooth muscle contraction || Gq, PLC -> IP3/DAG | + | | α1 || NE > Epi >> Iso |
| | | | | | |
| − | *Norepi | + | *Smooth muscle contraction, ↑SVR, ↑MAP |
| − | *Phenylephrine | + | *Mydriasis, urethral sphincter contraction |
| | + | | |
| | + | G<sub>q</sub> → PLC → IP<sub>3</sub>/DAG → [Ca<sup>2+</sup>]<sub>i</sub> |
| | + | | |
| | + | *NE |
| | + | *Phenylephrine (pure α1) |
| | *Midodrine | | *Midodrine |
| | | | | | |
| − | *Phenoxybenzamine
| + | '''α1 selective:''' |
| − | *Phentolamine
| |
| | *Prazosin | | *Prazosin |
| | *Tamsulosin | | *Tamsulosin |
| − | *Trazodone
| |
| | |- | | |- |
| − | | Alpha-2 || Epi = Norepi >> Iso || Mixed effects || Gi, presynaptic, cAMP down | + | | α2 || Epi = NE >> Iso |
| | + | | |
| | + | *↑SVR, ↑MAP |
| | + | *↓insulin release, ↓lipolysis, ↓aqueous humor production |
| | + | | |
| | + | presynaptic G<sub>i</sub> → ↓AC → ↓cAMP → ↓NT release |
| | | | | | |
| | *Dexmedetomidine | | *Dexmedetomidine |
| | *Clonidine | | *Clonidine |
| | | | | | |
| | + | '''Non-selective:''' |
| | *Phenoxybenzamine | | *Phenoxybenzamine |
| | *Phentolamine | | *Phentolamine |
| | *Trazodone | | *Trazodone |
| | |- | | |- |
| − | | Beta-1 || Iso > Norepi > Epi || Example || Gs, cAMP up | + | | β1 || Iso > NE > Epi |
| | + | | |
| | + | *↑Chronotropy (myocytes), ↑Inotropy (SA node), ↑SBP |
| | + | *↑Renin release/↑volume (JGA) |
| | + | *Amylase secretion |
| | + | | |
| | + | G<sub>s</sub> → ↑AC → ↑cAMP |
| | | | | | |
| | *Dobutamine | | *Dobutamine |
| Line 36: |
Line 51: |
| | *Esmolol | | *Esmolol |
| | |- | | |- |
| − | | Beta-2 || Iso > Epi > Norepi || Example || Gs, cAMP up | + | | β2 || Iso > Epi > NE |
| | + | | |
| | + | *Smooth muscle relaxation, ↓SVR, ↓DBP, ↓MAP |
| | + | *Bronchodilation |
| | + | *↑Lipolysis, ↑Insulin release |
| | + | *Relax uterine smooth muscle |
| | + | *↑aqueous humor production |
| | + | | |
| | + | G<sub>s</sub> → ↑AC → ↑cAMP → ↑PKA |
| | | | | | |
| | *Albuterol | | *Albuterol |
| Line 50: |
Line 73: |
| | *Pindolol | | *Pindolol |
| | *Timolol | | *Timolol |
| | + | *Carved'''ilol''' (anti-α1) |
| | + | *Labet'''alol''' (anti-α1) |
| | |- | | |- |
| − | | Beta-3 || Iso > Epi = Norepi || Example || Gs, cAMP up | + | | β3 || Iso > Epi = NE |
| | + | | |
| | + | *Lipolysis |
| | + | *Bladder detrusor relaxation |
| | + | | |
| | + | G<sub>s</sub> → ↑AC → ↑cAMP → ↑PKA |
| | | | | | |
| | *Mirabegron | | *Mirabegron |
| | | | | | |
| − | Example
| + | *SR 59230A |
| | |} | | |} |